Market growth influenced due to following factors-
- Rising government funding and growth in the number of genomics projects.
- Increasing production of genetically modified crops.
- High prevalence of infectious diseases and cancer, technological advancements.
- Growing application areas of genomics.
Global market size-
According to research report the global genome editing market is projected to reach $6.28 billion by 2022, at a CAGR of 14.5%.
> In 2019, Thermo Fisher Scientific acquired Brammer Bio to access Brammer Bio’s expertise in manufacturing vectors for genes and cell therapies> In 2019, Horizon Discovery launched predesigned synthetic single-guide RNA (sgRNA) to aid researchers in achieving targeted gene knockouts and conducting DNA-gene free editing> In 2020, New England Biolabs collaborated with ERS Genomics to develop and commercialize CRISPR gene editing tools and reagents
For Details, Download PDF Brochure Here
Top Segment –
•Based on technology, the genome editing market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE), and Jump-In). The CRISPR segment is expected to register the highest growth during the forecast period.
•Based on end user, the global genome engineering market is segmented into biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations.
•The global genome editing market, by application, is segmented into cell line engineering, genetic engineering, and other applications (diagnostics and therapeutics). The cell line engineering segment is estimated to register the highest growth rate during the forecast period.